Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 11.0653 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 11.1527 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 11.0792 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 10.9072 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 11.002 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 11.1031 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 10.9415 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 11.0012 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 10.877 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 11.0022 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 11.0802 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 11.1948 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 11.1094 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 11.2008 | 99 |